PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.
Saved in:
| Title: | PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab. |
|---|---|
| Authors: | Jensen, J. D.1,2, Knoop, A.1,2, Laenkholm, A. V.3, Grauslund, M.4, Jensen, M. B.5, Santoni-Rugiu, E.4, Andersson, M.6, Ewertz, M.1,2 |
| Source: | Annals of Oncology. Aug2012, Vol. 23 Issue 8, p2034-2042. 9p. 1 Diagram, 2 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdr546 |
